At DIGESTAID, we understand the critical importance of identifying anal cancer precursors. Fearlessly confronting challenges, we proudly took center stage at the prestigious 2023 Scientific Meeting of the International Anal Neoplasia Society in San Juan, Puerto Rico, this weekend—an assembly of the foremost experts in anal cancer and high-resolution anoscopy, marking a pivotal moment in scientific development in the field.

Our CEO, Professor Miguel Mascarenhas, delivered a captivating lecture on “Artificial Intelligence (AI) to Differentiate HSIL from LSIL.” This presentation, honored with the “People’s Choice for Best Presenter” award, acknowledges the invaluable role of AI in high-resolution anoscopy. It sparked intense interest, fostering insightful discussions among experts in anal cancer and high-resolution anoscopy.

DIGESTAID remains unwavering in its commitment to pioneering this vital mission. Stay connected for the latest developments in leveraging AI for diagnosing anal cancer precursors. Together, let’s advance the future of early detection!